- Email: [email protected]
The Journal for Nurse Practitioners Continuing Education Credit Application
The Journal for Nurse Practitioners Continuing Education Credit Application Title: Bisphosphonates and Atypical Femoral Fractures CE Code: TJNP42015 Valid until: 5-1-2017 This activity has been awarded 1.0 Contact Hours of which 1.0 credits are in the area of Pharmacology. Circle the best answer for each question. Required minimum passing score is 70%. 1. How many prescriptions were dispensed for oral bisphosphonates in the United States in 2012? A. Between 2 and 4 million B. Between 6 and 8 million C. Between 9 and 11 million D. Between 14 and 16 million
5. All of these factors control the degree of bone strength except: A. Body weight B. Mineralization C. Collagen and mineral quality D. Degree of microdamage
2. Atypical femoral fractures are located in femur A. Neck B. Mid-shaft C. Distal end D. Medial cortex
6. Which of the collagen statements is true? A. It plays a minor role in bone strength B. It makes up 90% of bone’s organic matrix C. Collagen molecules function without linkage to each other D. Areas of bone with older bone tissue have disproportionately less nonenzymatic collagen crosslinks
3. Which statement regarding the major features of atypical femoral fractures is not true? A. They are associated with trauma B. If untreated, the fracture line progresses towards a complete fracture C. The site of the fracture exhibits localized endosteal or periosteal cortex thickening D. The fracture is minimally comminuted or noncomminuted 4. Which statement about bisphosphonates is true? A. The half-life is approximately 5 years B. They are metabolized by the liver C. They get internalized into osteoclasts through endocytosis and engulfed in the cell D. They bind to bone surface at inactive remodeling areas
7. All A. B. C. D.
of these factors contribute to bone formation except: Calcium Vitamin D Bone anabolic agents Vitamin E
8. If an NP identifies a visible femoral fracture line in someone with a suspected atypical femoral fracture, she or he should: A. Order a nuclear bone scan B. Order a magnetic resonance image C. Refer for surgical intramedullary rodding D. Monitor the clinical course for several months
EVALUATION OF THE CE ACTIVITY Purpose and Target Audience: This CE learning activity is designed to augment the knowledge, skills, and attitudes of nurse practitioners and their understanding of bisphosphonates and the risk of atypical femoral fractures (AFFs).
1. Listed below are the educational activity objectives. Please rate the extent to which you are now able to meet each of the objectives or your level of agreement with the statements: (With 1 as the lowest or “no” ; 5 as the highest or “yes” ranking) a. Describe the risks associated with long-term bisphosphonate use
Low 1 2
3
4
High 5
b. Discuss pharmacology/pathogenesis of AFFs
1
2
3
4
5
c. Plan appropriate treatment and prevention strategies regarding AFFs
1
2
3
4
5
www.npjournal.org
The Journal for Nurse Practitioners - JNP
397
2. 3. 4. 5. 6. 7. 8. 9.
Low The teaching method was appropriate and effective for the content presented 1 The information presented was accurate, current, and at an appropriate level 1 This activity met my personal professional expectations 1 This content was relevant to my practice as an NP 1 This content will cause me to change my practice as an NP 1 I believe I will face barriers in my practice to implementing this information 1 Overall, I would rate this activity 1 Minutes required to read the article and complete all these questions __________
2 2 2 2 2 2 2
3 3 3 3 3 3 3
4 4 4 4 4 4 4
High 5 5 5 5 5 5 5
To receive CE credits, read the article, answer each question, and mail the test answers and evaluation along with your processing fee check for $10 made out to Elsevier, PO Box 1461, American Fork, UT 84003. CE is provided without charge to subscribers registered at www.npjournal.org and to AANP members who take the activity online.
Please Print Clearly Name: ______________________________________ Date CE activity completed: __________________ Address for mailing certificate: _____________________________________________________________ Phone number: ________________________ Email: _____________________________________________ This educational activity is provided by Nurse Practitioner Alternatives. Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation Accreditation of this activity does not imply endorsement by the provider, ANCC, or Elsevier of any commercial products mentioned in conjunction with this activity. For questions, contact [email protected].
COMMENTS:
398
The Journal for Nurse Practitioners - JNP
Volume 11, Issue 4, April 2015
5. All of these factors control the degree of bone strength except: A. Body weight B. Mineralization C. Collagen and mineral quality D. Degree of microdamage
2. Atypical femoral fractures are located in femur A. Neck B. Mid-shaft C. Distal end D. Medial cortex
6. Which of the collagen statements is true? A. It plays a minor role in bone strength B. It makes up 90% of bone’s organic matrix C. Collagen molecules function without linkage to each other D. Areas of bone with older bone tissue have disproportionately less nonenzymatic collagen crosslinks
3. Which statement regarding the major features of atypical femoral fractures is not true? A. They are associated with trauma B. If untreated, the fracture line progresses towards a complete fracture C. The site of the fracture exhibits localized endosteal or periosteal cortex thickening D. The fracture is minimally comminuted or noncomminuted 4. Which statement about bisphosphonates is true? A. The half-life is approximately 5 years B. They are metabolized by the liver C. They get internalized into osteoclasts through endocytosis and engulfed in the cell D. They bind to bone surface at inactive remodeling areas
7. All A. B. C. D.
of these factors contribute to bone formation except: Calcium Vitamin D Bone anabolic agents Vitamin E
8. If an NP identifies a visible femoral fracture line in someone with a suspected atypical femoral fracture, she or he should: A. Order a nuclear bone scan B. Order a magnetic resonance image C. Refer for surgical intramedullary rodding D. Monitor the clinical course for several months
EVALUATION OF THE CE ACTIVITY Purpose and Target Audience: This CE learning activity is designed to augment the knowledge, skills, and attitudes of nurse practitioners and their understanding of bisphosphonates and the risk of atypical femoral fractures (AFFs).
1. Listed below are the educational activity objectives. Please rate the extent to which you are now able to meet each of the objectives or your level of agreement with the statements: (With 1 as the lowest or “no” ; 5 as the highest or “yes” ranking) a. Describe the risks associated with long-term bisphosphonate use
Low 1 2
3
4
High 5
b. Discuss pharmacology/pathogenesis of AFFs
1
2
3
4
5
c. Plan appropriate treatment and prevention strategies regarding AFFs
1
2
3
4
5
www.npjournal.org
The Journal for Nurse Practitioners - JNP
397
2. 3. 4. 5. 6. 7. 8. 9.
Low The teaching method was appropriate and effective for the content presented 1 The information presented was accurate, current, and at an appropriate level 1 This activity met my personal professional expectations 1 This content was relevant to my practice as an NP 1 This content will cause me to change my practice as an NP 1 I believe I will face barriers in my practice to implementing this information 1 Overall, I would rate this activity 1 Minutes required to read the article and complete all these questions __________
2 2 2 2 2 2 2
3 3 3 3 3 3 3
4 4 4 4 4 4 4
High 5 5 5 5 5 5 5
To receive CE credits, read the article, answer each question, and mail the test answers and evaluation along with your processing fee check for $10 made out to Elsevier, PO Box 1461, American Fork, UT 84003. CE is provided without charge to subscribers registered at www.npjournal.org and to AANP members who take the activity online.
Please Print Clearly Name: ______________________________________ Date CE activity completed: __________________ Address for mailing certificate: _____________________________________________________________ Phone number: ________________________ Email: _____________________________________________ This educational activity is provided by Nurse Practitioner Alternatives. Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation Accreditation of this activity does not imply endorsement by the provider, ANCC, or Elsevier of any commercial products mentioned in conjunction with this activity. For questions, contact [email protected].
COMMENTS:
398
The Journal for Nurse Practitioners - JNP
Volume 11, Issue 4, April 2015